I.E. Medica and MedEthix, first local pharma companies to win prestigious healthcare awards in Singapore

MedEthix was recognized for leveraging the synergy of strategic alliances to ease Molnupiravir access in the Philippines during the height of the COVID-19 pandemic.

I.E. Medica was also awarded for its efforts in implementing solutions to its end-to-end supply chain operations to meet the nation's healthcare product supply chain needs.

The Philippines’ major pharmaceutical importers and distributors, I.E. Medica, Inc. and MedEthix Incorporated, were recently awarded three (3) major healthcare awards at the Healthcare Asia Pharma Awards 2024 at Marina Bay Sands, Singapore.

The pharmaceutical companies received the Supply Chain Initiative of the Year, Hospital Partnership of the Year, and the Most Differentiated Service of the Year awards. This marks the first time native Philippine pharmaceutical brands have won in these categories. The brands are active proponents in the importation, registration, and supply of healthcare products in the Philippines.

I.E. Medica and MedEthix executives, Monaliza Balnig Salian, co-founder, president and CEO, and Ma. Victoria P. Sugapong, COO, accepted the awards on behalf of the pharma group.

In her acceptance speech, Monaliza B. Salian said, “The Philippine pharmaceutical industry is heavily dependent on importation; thus, we continuously look for ways to improve our supply chain operations. As a young pharma group, I.E. Medica and MedEthix are aware of the overwhelming need of our countrymen for quality, affordable, and accessible healthcare solutions—and so we will continue to respond to these unmet needs, as Filipinos, for the Filipino.”

Salian’s acceptance speech in the prestigious awards program is a fitting capstone to the young local pharma group’s contribution to easing the burden of healthcare for Filipinos.  The awards conferred by the respected regional publication Healthcare Asia magazine put I.E. Medica and MedEthix in the league of outstanding pharma companies in Asia and the Pacific that have demonstrated an unwavering commitment to innovation and excellence and have redefined pharmaceutical excellence.

I.E. Medica: Implementing enhanced end-to-end supply chain operations that could enhance the nation’s healthcare product supply chain requirements

I.E. Medica is driven to continuously improve its supply chain operations to comply with Philippine Customs Administration import guidelines: from obtaining the Super Green Lane certificate in 2017 to having demonstrated its initial compliance with the cargo security risk management framework required for accreditation as an Authorized Economic Operator (AEO) Importer.

The company is also on track to securing the Level 1 AEO Certification, affirming its observance of supply chain security standards and the benefits of improved accessibility to healthcare goods brought about by streamlined import-export systems across borders, ultimately benefiting Filipinos and earning it the Supply Chain Initiative of the Year award.

MedEthix: Introducing a game-changing COVID-19 treatment in the country 

The impact of COVID-19 has been widespread, with its magnitude affecting the stability of social, economic, and political structures in many countries. It has particularly challenged national healthcare systems and their capacity to respond to large-scale outbreaks.

Filipino pharmaceutical company MedEthix went beyond its way as the first importer to secure its first four (4) hospital partners from the Food and Drug Administration (FDA) and the compassionate special permit (CSP) for Molnupiravir. This oral drug is indicated for mild to moderate cases of COVID-19 infection, enabling the standard of care to go beyond the confines of the overstretched hospital wards into the comforts of the patient’s home.

MedEthix further expanded the distribution of Molnupiravir from the first 4 CSP grantees to over 80 health institutions and over 500 doctors across the country as soon as it successfully secured the Emergency Use Authorization from the regulatory authority. Healthway QualiMed, the hospital network of AC Health, played a valuable role in its success. The hospital network, along with I.E. Medica and MedEthix, are partners of AC Health. The expanded access to affordable alternative treatment for COVID-19 greatly benefited Filipinos during the pandemic and earned the company the Hospital Partnership and The Most Differentiated Service of the Year awards.

A commitment to every Filipino

As the recipients of the three prestigious awards for the pharma category in the Philippines, I.E. Medica and MedEthix remain committed to providing a wide range of products that cover almost all therapeutic areas to meet the ever-changing healthcare needs of Filipinos. 

As the men and women of I.E. Medica and MedEthix interact with doctors, retail outlets, distributors, suppliers, regulatory authorities, and consumers daily, the hallmark of excellence exemplified by the three awards continues to inspire them to make a difference in the lives of their countrymen.